Page last updated: 2024-10-22

tyrphostin 25 and Leishmaniasis

tyrphostin 25 has been researched along with Leishmaniasis in 1 studies

Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

Research Excerpts

ExcerptRelevanceReference
"Genistein treatment of Leishmania-infected cells significantly enhanced the parasite burden."1.29Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection. ( Assreuy, J; Borges, VM; Cunha e Silva, NL; de Souza, W; Martiny, A; Meyer-Fernandes, JR; Vannier-Santos, MA, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martiny, A1
Vannier-Santos, MA1
Borges, VM1
Meyer-Fernandes, JR1
Assreuy, J1
Cunha e Silva, NL1
de Souza, W1

Other Studies

1 other study available for tyrphostin 25 and Leishmaniasis

ArticleYear
Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection.
    European journal of cell biology, 1996, Volume: 71, Issue:2

    Topics: Animals; Benzoquinones; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect;

1996